Claudio Denzlinger
Impact in
- Biochemistry top 2%
- Sulfur Compounds in Biology
- Eicosanoids and Hypertension Pharmacology
- Immunology top 5%
- Immune Response and Inflammation
Papers in
- Oncology 25
- Colorectal Cancer Treatments and Studies 10
- Neutropenia and Cancer Infections 6
- Chemokine receptors and signaling 5
- Immunology 19
- Immune Response and Inflammation 12
- Mast cells and histamine 5
- Co-authors
- Dietrich Keppler (11 shared papers)Wolfgang Hagmann (8 shared papers)S. Rapp (3 shared papers)Peter Brossart (3 shared papers)Alessio Nencioni (3 shared papers)Frank Grünebach (3 shared papers)Lothar Kanz (6 shared papers)Robert Möhle (5 shared papers)
In The Last Decade
Claudio Denzlinger
67 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 92
- Biochemistry 275
- Immunology 506
- Immunology and Allergy 117
- Hematology 219
- Hepatology 128
Countries citing papers authored by Claudio Denzlinger
This map shows the geographic impact of Claudio Denzlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Denzlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Denzlinger more than expected).
Fields of papers citing papers by Claudio Denzlinger
This network shows the impact of papers produced by Claudio Denzlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Denzlinger. The network helps show where Claudio Denzlinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Claudio Denzlinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 176 | |
| 2 | 1985 | 176 | |
| 3 | 1985 | 171 | |
| 4 | 1986 | 111 | |
| 5 | 2001 | 96 | |
| 6 | Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action. | 1984 | 96 |
| 7 | 1985 | 93 | |
| 8 | 1986 | 90 | |
| 9 | 2017 | 66 | |
| 10 | Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. | 2004 | 63 |
| 11 | 2005 | 63 | |
| 12 | 2011 | 49 | |
| 13 | 2003 | 46 | |
| 14 | 1995 | 39 | |
| 15 | 2002 | 38 | |
| 16 | 2001 | 35 | |
| 17 | 2018 | 34 | |
| 18 | 1999 | 33 | |
| 19 | 1996 | 33 | |
| 20 | 1998 | 30 |
About Claudio Denzlinger
Claudio Denzlinger is a scholar working on Oncology, Immunology, Physiology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immune Response and Inflammation (12 papers), Colorectal Cancer Treatments and Studies (10 papers), Asthma and respiratory diseases (10 papers), Neutropenia and Cancer Infections (6 papers), Mast cells and histamine (5 papers), Blood disorders and treatments (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Chemokine receptors and signaling (5 papers). The work is most often cited by research in Biochemistry (275 citations), Immunology (506 citations), Immunology and Allergy (117 citations), Hematology (219 citations) and Hepatology (128 citations). Claudio Denzlinger has collaborated with scholars based in Germany, Italy and Belgium. Frequent co-authors include Dietrich Keppler, Wolfgang Hagmann, S. Rapp, Peter Brossart, Alessio Nencioni, Frank Grünebach, Lothar Kanz, Robert Möhle, W. Wilmanns and Wolfram Brugger. Their work appears in journals such as Blood, European Journal of Cancer, The Journal of Immunology, Journal of Clinical Oncology and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.